Your browser doesn't support javascript.
loading
Future perspectives in diabesity treatment: Semaglutide, a glucagon-like peptide 1 receptor agonist (Review).
Tilinca, Mariana Cornelia; Tiuca, Robert Aurelian; Niculas, Cristina; Varga, Andreea; Tilea, Ioan.
Affiliation
  • Tilinca MC; Department of Internal Medicine, 'George Emil Palade' University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.
  • Tiuca RA; Compartment of Diabetology, Emergency Clinical County Hospital, 540136 Targu Mures, Romania.
  • Niculas C; Department of Endocrinology, 'George Emil Palade' University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.
  • Varga A; Department of Endocrinology, Mures County Clinical Hospital, 540139 Targu Mures, Romania.
  • Tilea I; Richter Pharmacy 7, 400129 Cluj Napoca, Romania.
Exp Ther Med ; 22(4): 1167, 2021 Oct.
Article in En | MEDLINE | ID: mdl-34504612
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Exp Ther Med Year: 2021 Type: Article Affiliation country: Romania
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Exp Ther Med Year: 2021 Type: Article Affiliation country: Romania